Abemaciclib-[d7]

Ask the supplier | View on supplier's website

Labelled Abemaciclib. Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. It is used for the treatment of advanced or metastatic breast cancers.

Supplier	BOC Sciences
Product #	BLP-003177
Pricing	Inquire
Molecular Weight	513.64
Molecular Formula	C27H25D7F2N8

Feedback